Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities

NCT ID: NCT02552017

Last Updated: 2015-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1772 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if a new device, called the Endocuff Vision (a small plastic device attached to the end of the colonoscope which helps by holding the folds of the bowel back to give a clear view of the inside of the bowel) will significantly improve the detection of adenomas when used in all patients referred for colonoscopy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bowel cancer is common in the United Kingdom, with around 1 in 16 men and 1 in 20 women developing it at some point in their lives. Most bowel cancers happen when a type of polyp (a growth in the bowel) called an adenoma becomes cancerous. Doctors use a camera test, known as a colonoscopy, to look inside the bowel and find these polyps and remove them. Removing precancerous polyps is known to reduce the chances of a person developing bowel cancer in the future. How good colonoscopists are at finding these polyps varies, and there is a lot of research into how to improve "adenoma detection rates".

A new device, called the Endocuff Vision (a small plastic device attached to the end of the colonoscope which helps by holding the folds of the bowel back to give a clear view of the inside of the bowel) has been shown to improve the rate of polyp detection at colonoscopy, and to make polyp removal easier. Previous small studies have shown that there is a significant improvement in detection of adenomas when an Endocuff Vision is used (with the rate of detection of adenomas rising from 49% to 66%). Colonoscopists who have used the Endocuff Vision before also feel that polyp removal is easier when it is on the colonoscope. This study will randomise patients coming for colonoscopy to have their procedure performed as usual (i.e. without the Endocuff Vision attached) or as an Endocuff Vision-assisted colonoscopy. The investigators will record polyp and adenoma detection rates, duration of procedure, participant comfort levels, and complications. All patients referred for colonoscopy (via the symptomatic service, surveillance procedures, and the Bowel Cancer Screening Programme) will be invited in 7 centres (a mixture of specialist centres and district general hospitals), recruiting a total of 1772 participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Neoplasms Colonic Polyps Adenoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endocuff Vision-assisted Colonoscopy

Participants in this arm undergo Endocuff Vision-assisted colonoscopy

Group Type ACTIVE_COMPARATOR

Endocuff Vision

Intervention Type DEVICE

Endocuff Vision is a new device made of soft plastic material with a unique dynamic shape. It is manufactured by ARC Medical Design Limited and Diagmed in the United Kingdom. It has European Conformity in United Kingdom. The core is made of polypropylene and the 'finger like' projections are made of a thermoplastic elastomer. It comes in four colour coded sizes (purple, blue, green and orange) to fit a range of paediatric and adult colonoscopes. Endocuff Vision is the more updated version of device that has only one proximal row of more rounded finger-like projections. It is mounted at the tip of the colonoscope and held on by friction (pull-off force is a minimum of 10 Newtons).

Standard Colonoscopy

Participants in this arm undergo standard colonoscopy

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endocuff Vision

Endocuff Vision is a new device made of soft plastic material with a unique dynamic shape. It is manufactured by ARC Medical Design Limited and Diagmed in the United Kingdom. It has European Conformity in United Kingdom. The core is made of polypropylene and the 'finger like' projections are made of a thermoplastic elastomer. It comes in four colour coded sizes (purple, blue, green and orange) to fit a range of paediatric and adult colonoscopes. Endocuff Vision is the more updated version of device that has only one proximal row of more rounded finger-like projections. It is mounted at the tip of the colonoscope and held on by friction (pull-off force is a minimum of 10 Newtons).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. All patients referred for screening, surveillance, or diagnostic colonoscopy
2. All patients must be able to give informed consent

Exclusion Criteria

1. Patients with any absolute contraindications to colonoscopy
2. Patients with established or suspicion of large bowel obstruction or pseudo-obstruction
3. Patients with known colon cancer or polyposis syndromes
4. Patients with known colonic strictures
5. Patients with known severe diverticular segments (that is likely to impede colonoscope passage)
6. Patients with active colitis (ulcerative colitis, Crohn's colitis, diverticulitis, infective colitis)
7. Patients lacking capacity to give informed consent
8. Pregnancy
9. Patients who are on clopidogrel, warfarin, or other new generation anticoagulants who have not stopped this for the procedure.
10. Patients who are attending for a therapeutic procedure or assessment of a known lesion
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

South Tyneside and Sunderland NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Colin Rees, MBBS, FRCP

Role: PRINCIPAL_INVESTIGATOR

South Tyneside and Sunderland NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

County Durham and Darlington NHS Foundation Trust

Durham, County Durham, United Kingdom

Site Status RECRUITING

North Tees and Hartlepool NHS Foundation Trust

Stockton-on-Tees, County Durham, United Kingdom

Site Status RECRUITING

St Mark's Hospital and Academic Institute

Harrow, Middlesex, United Kingdom

Site Status RECRUITING

South Tees Hospitals NHS Foundation Trust

Middlesbrough, North Yorkshire, United Kingdom

Site Status RECRUITING

Northumbria Healthcare NHS Foundation Trust

North Shields, Tyne and Wear, United Kingdom

Site Status RECRUITING

South Tyneside NHS Foundation Trust

South Shields, Tyne and Wear, United Kingdom

Site Status RECRUITING

City Hospitals Sunderland NHS Foundation Trust

Sunderland, Tyne and Wear, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wee Sing Ngu, MBChB, MRCS

Role: CONTACT

01914041000 ext. 2899

Gayle Clifford, BSc

Role: CONTACT

01914041000 ext. 4756

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

John Silcock, MBBS, FRCP

Role: primary

01325 380100

Matthew Rutter, MBBS, FRCP

Role: primary

01642 617617

Brian Saunders, MBBS, FRCP

Role: primary

02082354000

Arvind Ramadas, MBBS, FRCP

Role: primary

01642 854860

Thomas Lee, MBBS, FRCP

Role: primary

0344 811 8111

Wee Sing Ngu, MBChB, MRCS

Role: primary

01914041000 ext. 2899

Gayle Clifford, BSc

Role: backup

01914041000 ext. 4756

John Painter, MBBS, FRCP

Role: primary

0191 565 6256

References

Explore related publications, articles, or registry entries linked to this study.

Ngu WS, Bevan R, Tsiamoulos ZP, Bassett P, Hoare Z, Rutter MD, Clifford G, Totton N, Lee TJ, Ramadas A, Silcock JG, Painter J, Neilson LJ, Saunders BP, Rees CJ. Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial. Gut. 2019 Feb;68(2):280-288. doi: 10.1136/gutjnl-2017-314889. Epub 2018 Jan 23.

Reference Type DERIVED
PMID: 29363535 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17718

Identifier Type: REGISTRY

Identifier Source: secondary_id

1182104

Identifier Type: REGISTRY

Identifier Source: secondary_id

039/2014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AI Colorectal Polyp Detection
NCT04979962 COMPLETED NA